SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anthem Biosciences - Quaterly Results

22 Jul 2026 Evaluate
The sales declined to Rs. 3838.42 millions for the June 2026 quarter as compared to Rs. 5380.11 millions during the corresponding quarter last year.Net profit of the cmpany stood at Rs. 1020.10 millions for the quarter ended June 2026 a decline of -31.23% from Rs. 1483.41 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 1594.33 millions from 2231.57 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3838.42 5380.11 -28.66 3838.42 5380.11 -28.66 20893.12 18406.49 13.51
Other Income 286.00 277.28 3.14 286.00 277.28 3.14 1820.75 1094.40 66.37
PBIDT 1594.33 2231.57 -28.56 1594.33 2231.57 -28.56 10331.96 7984.49 29.40
Interest 7.63 16.06 -52.49 7.63 16.06 -52.49 65.47 90.89 -27.97
PBDT 1586.70 2215.51 -28.38 1586.70 2215.51 -28.38 10026.36 7893.60 27.02
Depreciation 223.10 226.12 -1.34 223.10 226.12 -1.34 995.65 779.37 27.75
PBT 1363.60 1989.39 -31.46 1363.60 1989.39 -31.46 9030.71 7114.23 26.94
TAX 343.50 505.98 -32.11 343.50 505.98 -32.11 2325.06 2052.36 13.29
Deferred Tax -3.55 5.29 -167.11 -3.55 5.29 -167.11 -87.99 232.08 -137.91
PAT 1020.10 1483.41 -31.23 1020.10 1483.41 -31.23 6705.65 5061.87 32.47
Equity 1126.77 1123.22 0.32 1126.77 1123.22 0.32 1123.43 1118.15 0.47
PBIDTM(%) 41.54 41.48 0.14 41.54 41.48 0.14 49.45 43.38 14.00

Anthem Biosciences Share Price

778.35 -13.35 (-1.69%)
22-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.95
Dr. Reddys Labs. 1183.00
Cipla 1415.10
Lupin 2405.80
Zydus Lifesciences 1129.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: